Raphael Pharmaceutical Inc (RAPH)
1.00
0.00 (0.00%)
USD |
OTCM |
May 09, 16:00
Raphael Pharmaceutical Cash from Investing (Quarterly): 0.00 for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | |
March 31, 2023 | |
December 31, 2022 | 0.00 |
September 30, 2022 | -0.002M |
Date | Value |
---|---|
June 30, 2022 | |
March 31, 2022 | |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
March 31, 2021 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-0.002M
Minimum
Sep 2022
--
Maximum
Mar 2021
-0.0003M
Average
--
Median
Mar 2021
Cash from Investing (Quarterly) Benchmarks
InspireMD Inc | -0.036M |
Pluri Inc | 3.919M |
BiomX Inc | -0.006M |
Alpha Tau Medical Ltd | -- |
Holdco Nuvo Group DG Ltd | -- |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -0.088M |
Cash from Financing (Quarterly) | 0.019M |
Free Cash Flow | -1.203M |
Free Cash Flow Per Share (Quarterly) | -0.005 |
Free Cash Flow Yield | -7.32% |